Correction to: Journal of Human Hypertension (2021) 36:153-162

https://doi.org/10.1038/s41371-021-00492-w, published online 08 March 2021

The authors would like to correct Table 1, as errors were introduced in the preparation of this table for publication. The authors declare that the corrections do not alter the scientific results or conclusions of this paper, and apologize for any inconvenience caused. The authors have provided corrected version of Table 1 here.

The original article has been corrcted.

Former Table 1:

Table 1 Clinical parameters and biochemical indicators of LN patients with or without hypertension.

 

Overall (n = 1406)

Hypertensive (n = 764)

Normotensive (n = 642)

P values

Age, years

31.45 ± 12.58

33.23 ± 13.29

29.34 ± 11.34

<0.001

Male, n (%)

241 (17.1%)

144 (18.8%)

97 (15.1%)

0.064

Duration of lupus, months

61 (11, 126)

60 (9.2, 128)

61 (12, 124)

0.797

Duration of LN, months

53 (9, 119)

53.5 (8, 119)

52 (9.7, 119)

0.643

AI score

6 (5,8)

7 (5,9)

6 (4,8)

<0.001

CI score

3 (2,4)

4 (2,5)

3 (2,4)

<0.001

AKI, n (%)

222 (15.8)

154 (20.2)

68 (10.6)

<0.001

CKD stage

   

<0.001

 CKD1, n (%)

715 (38.6)

181 (23.7)

363 (56.5)

 

 CKD2, n (%)

198 (19.9)

155 (20.3)

125 (19.5)

 

 CKD3, n (%)

222 (17.6)

149 (19.5)

99 (15.4)

 

 CKD4, n (%)

126 (10.7)

115 (15.1)

35 (5.5)

 

 CKD5, n (%)

134 (13.1)

164 (21.5)

20 (3.1)

 

Serum creatinine, μmol/L

175.52 ± 104.34

233.50 ± 103.45

106.51 ± 58.04

<0.001

Serum creatinine >133 μmol/L, n (%)

484 (34.4%)

383 (50.1%)

111 (17.3%)

<0.001

BUN, mmol/L

12.12 ± 9.66

15.01 ± 10.50

8.70 ± 7.20

<0.001

eGFR, mL/min/1.73 m2

79.36 ± 64.72

58.84 ± 47.42

103.79 ± 73.53

<0.001

Hemoglobin, g/L

94.30 ± 27.03

89.59 ± 26.00

100.00 ± 27.18

<0.001

Urinary total protein, g/24 h

2.53 ± 0.73

2.90 ± 1.2

2.01 ± 0.45

<0.001

Positive ANA, n (%)

1301 (92.5)

699 (91.5)

602 (93.8)

0.108

Positive dsDNA, n (%)

1063 (75.6)

573 (75)

490 (76.3)

0.576

Positive Sm, n (%)

413 (29.4%)

217 (28.4)

196 (30.5)

0.383

Complement C3, mmo/L

0.51 ± 0.27

0.52 ± 0.26

0.51 ± 0.28

0.684

Cholesterol, mmol/L

6.08 ± 2.54

6.37 ± 2.67

5.73 ± 2.33

<0.001

TG, mmol/L

2.46 ± 1.54

2.62 ± 1.66

2.27 ± 1.37

<0.001

HDL-c, mmol/L

1.10 ± 0.50

1.10 ± 0.50

1.12 ± 0.51

0.460

LDL-c, mmol/L

3.51 ± 1.74

3.67 ± 1.80

3.32 ± 1.65

<0.001

Serum albumin, g/L

27.62 ± 7.37

26.90 ± 6.97

28.49 ± 7.74

<0.001

Serum uric acid, μmol/L

438.54 ± 251.46

468.11 ± 203.96

402.67 ± 295.38

<0.001

Calcium, mmol/L

2.00 ± 0.29

1.99 ± 0.29

2.01 ± 0.28

<0.001

Phosphorus, mmol/L

1.47 ± 0.54

1.58 ± 0.62

1.35 ± 0.40

<0.001

Corrected Table 1:

Table 1. Clinical parameters and biochemical indicators of LN patients with or without hypertension.

 

Overall (n = 1406)

Hypertensive (n = 764)

Normotensive (n = 642)

P-values

Age, years

31.45 ± 12.58

33.23 ± 13.29

29.34 ± 11.34

<0.001

Male, n (%)

241(17.1%)

144 (18.8%)

97 (15.1%)

0.064

Duration of lupus, months

61 (11, 126)

60 (9.2, 128)

61 (12, 124)

0.797

Duration of LN, months

53 (9, 119)

53.5 (8, 119)

52 (9.7, 119)

0.643

AI score

6 (5,8)

7 (5,9)

6 (4,8)

<0.001

CI score

3 (2,4)

4 (2,5)

3 (2,4)

<0.001

AKI, n (%)

222 (15.8)

154 (20.2)

68 (10.6)

<0.001

CKD stage

   

<0.001

 CKD1, n (%)

544 (38.7)

181 (23.7)

363 (56.5)

 

 CKD2, n (%)

280 (19.9)

155 (20.3)

125 (19.5)

 

 CKD3, n (%)

248 (17.6)

149 (19.5)

99 (15.4)

 

 CKD4, n (%)

150 (10.7)

115 (15.1)

35 (5.5)

 

 CKD5, n (%)

184 (13.1)

164 (21.5)

20 (3.1)

 

Serum creatinine, μmol/L

175.52 ± 104.34

233.50 ± 103.45

106.51 ± 58.04

<0.001

Serum creatinine >133 μmol/L, n (%)

484 (34.4%)

383 (50.1%)

111 (17.3%)

<0.001

BUN, mmol/L

12.12 ± 9.66

15.01 ± 10.50

8.70 ± 7.20

<0.001

eGFR, mL/min/1.73m2

79.36 ± 64.72

58.84 ± 47.42

103.79 ± 73.53

<0.001

Hemoglobin, g/L

94.30 ± 27.03

89.59 ± 26.00

100.00 ± 27.18

<0.001

Urinary total protein, g/24 hours

2.53 ± 0.73

2.90 ± 1.2

2.01 ± 0.45

<0.001

Positive ANA, n (%)

1301 (92.5)

699 (91.5)

602 (93.8)

0.108

Positive dsDNA, n (%)

1063 (75.6)

573 (75)

490 (76.3)

0.576

Positive Sm, n (%)

413 (29.4%)

217 (28.4)

196 (30.5)

0.383

Complement C3, mmo/L

0.51 ± 0.27

0.52 ± 0.26

0.51 ± 0.28

0.684

Cholesterol, mmol/L

6.08 ± 2.54

6.37 ± 2.67

5.73 ± 2.33

<0.001

TG, mmol/L

2.46 ± 1.54

2.62 ± 1.66

2.27 ± 1.37

<0.001

HDL-c, mmol/L

1.10 ± 0.50

1.10 ± 0.50

1.12 ± 0.51

0.460

LDL-c, mmol/L

3.51 ± 1.74

3.67 ± 1.80

3.32 ± 1.65

<0.001

Serum albumin, g/L

27.62 ± 7.37

26.90 ± 6.97

28.49 ± 7.74

<0.001

Serum uric acid, μmol/L

438.54 ± 251.46

468.11 ± 203.96

402.67 ± 295.38

<0.001

Calcium, mmol/L

2.00 ± 0.29

1.99 ± 0.29

2.01 ± 0.28

<0.001

Phosphorus, mmol/L

1.47 ± 0.54

1.58 ± 0.62

1.35 ± 0.40

<0.001